High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients

Cao, Dedong; Xu, Huilin; Xu, Ximing; Guo, Tao; Ge, Wei

doi:10.1080/2162402x.2019.1629258

Public

High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients

Published in OncoImmunology • Jun 16, 2019

Authors:

Dedong Cao

Huilin Xu

Ximing Xu

Abstract

The relation between tumor mutation burden (TMB) and outcome of cancer patients receiving immunotherapy has been reported. This study aimed to evaluate the prognostic role of TMB in cancer patients receiving immunotherapy. Databases including Embase, PubMed, and the Cochrane library were systematica...

Subject

Medicine

Immunotherapy

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!